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ABSTRACT
Poly-C-binding proteins are triple KH (hnRNP K
homology) domain proteins with specificity for
single stranded C-rich RNA and DNA. They play
diverse roles in the regulation of protein expression
at both transcriptional and translational levels. Here,
we analyse the contributions of individual aCP1 KH
domains to binding C-rich oligonucleotides using
biophysical and structural methods. Using surface
plasmon resonance (SPR), we demonstrate that
KH1 makes the most stable interactions with both
RNA and DNA, KH3 binds with intermediate affinity
and KH2 only interacts detectibly with DNA. The
crystal structure of KH1 bound to a 50-CCCTCCCT
-30 DNA sequence shows a 2:1 protein:DNA stoichi-
ometry and demonstrates a molecular arrangement
of KH domains bound to immediately adjacent
oligonucleotide target sites. SPR experiments, with
a series of poly-C-sequences reveals that cytosine
is preferred at all four positions in the oligonucleo-
tide binding cleft and that a C-tetrad binds KH1 with
10 times higher affinity than a C-triplet. The basis
for this high affinity interaction is finally detailed with
the structure determination of a KH1.W.C54S
mutant bound to 50-ACCCCA-30 DNA sequence.
Together, these data establish the lead role of KH1
in oligonucleotide binding by aCP1 and reveal the
molecular basis of its specificity for a C-rich tetrad.
INTRODUCTION
Poly-C-binding proteins (PCBP) are ubiquitous
oligonucleotide-binding proteins in eukaryotic cells that
play a fundamental role in the regulation of gene expres-
sion via interaction with C-rich oligonucleotides.
The family consists of the archetypal hnRNP K (heteroge-
neous nuclear ribonucleoprotein K) and isoforms of aCP1
(also known as PCBP and hnRNP E) including aCP1-4
and aCP-KL (1,2). The effects of binding by aCPs
vary—and are thought to be dependent upon the ternary
complex within which the aCPs are involved. aCPs are
involved at several levels of post-transcriptional gene regu-
lation. Within the nucleus, aCP binding at the 30-UTR or
intron 1 of a-globin mRNA impacts upon its splicing and
enhances its cleavage and polyadenylation (3,4). Outside
the nucleus, aCPs are implicated in the stabilization of
speciﬁc mRNAs, leading to the up-regulation of their
gene products. They have been shown to be sufﬁcient for
formation of the ‘a-complex’ at a speciﬁc C-rich region of
the 30-UTR of a-globin mRNA, causing its accumulation
during terminal erythroid differentiation (5,6). Binding of
aCPs to 30-UTR mRNA have been implicated in the sta-
bilization of tyrosine hydroxylase (7), erythropoietin (8),
b-globin (9) and collagen a1(I) (10) mRNAs. aCP proteins
have also been shown to effect translational control. Their
binding to a CU-rich region of the 30-UTR differentiation
control element (DICE) of 15-lipoxygenase mRNA along
with hnRNP K suppresses translation through interference
with the joining of the ribosomal 60S and 40S subunits at
the initiation AUG codon (11,12). Similarly, human
papillomavirus type 16 L2 mRNA appears to be silenced
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hancement has been reported due to aCP binding to the
50-UTR of the folate receptor mRNA (14), the 30-UTR of
phosphatase 2A mRNA (15) and the 50-UTR of picorna-
virus mRNA (16,17). Thus, aCP binding to RNA can
result in both silencing and enhancement of translation
through a diverse set of mechanisms.
InadditiontotheirmorerecognizedabilitytobindRNA,
aCPs have also been shown to bind single stranded DNA
(ssDNA). Such interactions play a role in transcriptional
regulation with aCP identiﬁed as the ssDNA binding
protein underlying proximal promoter activity of
mousem-opioid receptor (18). The closely related hnRNP
K is established as a transcription factor, binding to the CT
element in the promoter region of c-myc (19), and also to
speciﬁc ssDNA elements within the promoter region of a
neuronal nicotinic acetylcholine receptor gene (20). The
aCPs have also been found to recognize the C-rich strand
of human telomeric DNA with high afﬁnity (21). Of all
theaCPs,aCP1inparticular,showedremarkablespeciﬁcity
for the telomeric (CCCTAA)n repeat motif (22).
The structural basis for aCP interactions with oligo-
nucleotide is thus of interest, including the basis for their
afﬁnity and speciﬁcity for RNA and ssDNA.
Oligonucleotide binding by aCPs is via their triple K
homology (KH) domain structure, as ﬁrst identiﬁed in
hnRNP K (23). These type I KH domains are 68–72
amino acid structures involving a three-stranded
anti-parallel b-sheet packed against three a-helices
(baabba) (24). The two N-terminal KH domains of aCPs
are closely spaced, whereas the C-terminal KH domain is
separated by a linker of variable length. Nuclear localiza-
tion sequences in the linker regions between KH2 and KH3
and within KH3 of the aCPs have been shown to dictate
their differential subcellular localization (25). aCP1 and
aCP2 are predominantly nuclear, whereas aCP3 and
aCP4 are restricted to the cytoplasm and the splice
variant, aCP2-KL, is present in signiﬁcant amount in
both the nucleus and cytoplasm. It may be that this differ-
ential localization dictates the involvement of the aCP
family members in their various functions.
The three-dimensional structures of several aCP-KH
domains in apo- and oligonucleotide-bound form have
been reported including: aCP1–KH3, KH domains 1, 2
and 3 of aCP2 and hnRNPK-KH3 (26–31), providing
considerable insight into their basis of binding and speci-
ﬁcity. Oligonucleotide binding occurs at a cleft formed
across a-helix 1 and bounded by two unstructured
surface loops. The ﬁrst loop, between a-helices 1 and 2,
contains an invariant GXXG sequence, crucial to oligo-
nucleotide binding and forming contacts with the sugar–
phosphate backbone. The second loop, between b-strands
2 and 3, is of variable length and sequence, and ﬂanks the
edge of the RNA binding cleft that the bases are directed
towards. The oligonucleotide binding cleft is narrow and
reported to more readily accommodate pyrimidine over
purine bases, and four bases are accommodated within
the oligonucleotide binding site (26,27,31). Here, surpris-
ingly, speciﬁc contacts to cytosines at the two central pos-
itions are consistently observed, but the existence of
speciﬁcity at the ﬁrst and fourth position is still unclear.
Another feature of the aCP/oligonucleotide interaction
that is not completely understood concerns the relative
roles of the three KH domains and their overall topo-
logical arrangement when bound to target oligonucleotide
(32). The optimal target sequence of the aCP-2KL isoform
generated by in vitro SELEX contained three short C-rich
patches within an exposed single stranded conformation
spaced 2–6nt apart (33). This suggests a close spatial ar-
rangement of all three aCP KH domains. It is also notable
that the disruption of any of the three C-rich patches
within the aCP target site of a-globin mRNA interferes
with a-complex formation and decreases a-globin stability
in vivo (5,34). Interestingly, X-ray crystallographic and
nuclear magnetic resonance (NMR) spectroscopic
analysis of aCP KH domains reveal both hetero- and
homo-dimer formation between KH domains (29–31).
These protein–protein interactions can occur simultan-
eously to oligonucleotide binding. Whether these inter-
actions occur within the context of the full-length protein
bound to its target oligonucleotide is not yet known.
We have previously reported aCP binding to a speciﬁc
UC-rich region of the 30-UTR of androgen receptor
mRNA (35). Through mutual binding with HuR, aCP1
and aCP2 are thought to be a part of the post-
transcriptional control mechanism for androgen receptor
expression. They have been shown to bind to a speciﬁc
50-CCCUCCC-30 motif (AR mRNA nucleotides 3317–
3323) immediately adjacent to a U-rich sequence (AR
mRNA 3275–3316) which is the target for HuR binding.
It is speculated that the combination of aCP and HuR
binding plays a role in the regulation of AR mRNA
gene expression. Here, we report a binding analysis of
full-length aCP1, as well as the three separate aCP1–KH
domains to their target sequence in the 30-UTR of
androgen receptor mRNA using electrophoretic mobility
shift assays (EMSA) and surface plasmon resonance
(SPR). A binding comparison is made with the analogous
DNA sequence. We also report the crystallization and
structure determination of aCP1–KH1 bound to a target
DNA 11-mer analogous to the androgen receptor mRNA
target site. This structure reveals the mode of interaction
with the oligonucleotide, as well as the topological ar-
rangement of two aCP1–KH domains bound at adjacent
target sites. Further, SPR experiments are used to investi-
gate the preferential binding of cytosine at each of the four
nucleotide binding positions. This is further explored
using a structural approach in which we determine the
structure of a aCP1–KH1 mutant bound to a cytosine
tetrad. Together, our data establish the lead role of KH1
in oligonucleotide binding by aCP1 and reveal the molecu-
lar basis of its speciﬁcity to a C-rich tetrad.
MATERIALS AND METHODS
Protein expression and puriﬁcation
Full-lengthaCP1orindividualKHdomainswereexpressed
as fusion proteins with glutathione-S-transferase (GST).
The DNA coding sequences comprising amino acids 1–
356 (aCP1), 14–86 (aCP1–KH1), 97–150 (aCP1–KH2)
and 279–356 (aCP1–KH3), were cloned into pGEX-6P2
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+)
inLuriaBrothat37 C.Proteinexpressionwasinducedwith
0.02mM IPTG (isopropyl-D-thiogalactoside) at an optical
densityof0.8at595nm.Thecellswereharvestedafter3hof
furthergrowthbycentrifugation,resuspendedinphosphate
buffered saline (PBS) (140mM NaCl, 2.7mM KCl, 10mM
Na2HPO4, 1.8mM KH2PO4, pH 7.4) containing 0.5%
Triton X-100 and was then lysed by French Pressing
(SLM Instruments, Inc.), supplemented with 0.5mM
phenylmethanesulphonyl ﬂuoride (PMSF) and, in the case
of full-length aCP1, a cocktail of protease inhibitors were
used including aprotinin (2mg/ml), leupeptin (2mg/ml) and
pepstatin (1mg/ml). The GST-fusion proteins were puriﬁed
by afﬁnity chromatography using glutathione agarose
beads equilibrated with PBS buffer at 4 C and the GST
was cleaved using 2U Prescission protease (GE
Healthcare) in 50mM Tris–HCl, pH 7.0, 150mM NaCl,
1mM EDTA, 1mM dithiothreitol (DTT) at 4 C. aCP1
was ﬁnally puriﬁed using anion exchange chromatography
(Mono-Q Pharmacia) and aCP1–KH1 and aCP1–KH2
puriﬁed by size exclusion chromatography using a
Sephadex 75 column (Pharmacia). The puriﬁed proteins
were dialysed into phosphate buffer pH 6.0 (1mM DTT,
25mM NaH2PO4, 150mM NaCl, 1mM EDTA),
concentrated with centrifugal concentrators of 3K cut-off
(Millipore) and quantiﬁed using a detergent compatible
(Biorad) protein assay. The cloning, overexpression and
puriﬁcation of the aCP1–KH1.W.C54S mutant protein is
as described previously (36). In brief, this protein was
prepared as a His-tagged protein, and the His-tag was not
removed prior to crystallization trials.
Preparation of oligonucleotides for EMSA
Long RNA transcript. A 107nt RNA containing vector
sequences and nucleotides 3275–3325 of the androgen
receptor mRNA 30UTR was generated from the relevant
DNA and cloned into pBLUESCRIPT II KS+ using
Ambion in vitro transcription kits according to manufac-
turers speciﬁcations. After puriﬁcation of full-length
transcripts on denaturing polyacrylamide gels, RNAs
were end-labelled with g[
32P]ATP (Perkin Elmer).
Radiolabelled RNAs were subjected to a second round
of denaturing gel puriﬁcation, then eluted, precipitated
and resuspended in water. Prior to use, radiolabelled
RNAs were heated to 70 C for 10min, then quenched
on ice and diluted to 2  the ﬁnal concentration.
Short oligonucleotides. Synthetic RNA sequence 50-UUC
CCUCCCUA-30 corresponding to nucleotides 3315–3325
of AR mRNA, was purchased from Dharmacon (Dallas,
Tx). The analogous synthetic DNA, of sequence 50-TTCC
CTCCCTA-30, was purchased from Sigma Genosys
(Castle Hill, NSW, Australia). Both were gel puriﬁed
and 50-end labelled as described above.
RNA and DNA EMSA
The EMSA was utilized for examining the binding of
full-length aCP1 and aCP1–KH1 to target RNA and
DNA. Puriﬁed full-length aCP1 and aCP1–KH1 were
thawed and diluted to 2  the ﬁnal concentration in
binding buffer [10mM HEPES pH 7.5, 3mM MgCl2,
14mM KCl, 5% (v/v) glycerol, 0.2% (v/v) Nonidet
P-40, 1mM DTT]. A quantity of 5ml of diluted protein
was mixed with 1ml of tRNA (1mg/ml) and incubated at
room temperature for 10min to prevent non-speciﬁc
binding, before addition of an equal volume of labelled
probe, also diluted to 2  the ﬁnal concentration in
binding buffer. After 30min incubation at room tempera-
ture, 4ml of loading dye [binding buffer also containing
50% (v/v) glycerol, 0.1% (w/v) bromophenol blue and
0.1% (w/v) xylene cyanol] was added and the mixture
loaded immediately on to a running non-denaturing poly-
acrylamide/0.5   tris/borate/ ethylenediaminetetraacetic
acid (TBE) gel and run at 10V/cm. After electrophoresis,
the gel was dried and then exposed to either a
phosphorimager plate or X-ray ﬁlm overnight for detec-
tion of protein and oligonucleotide complexes.
SPR studies
SPR (using a BIAcore 2000 or T100 instrument) was
employed to characterize the aCP1–KH domain inter-
actions with target RNA and DNA. A research grade
CM5 chip coated with streptavidin was purchased from
BIAcore. For comparison of KH1, KH2 and KH3
binding, 50-biotinylated mRNA (50-CUCUCCUUUCUU
UUUCUUCUUCCCUCCCUA-30) representing nucleo-
tides 3296–3325 of androgen receptor mRNA was
obtained from Dharmacon and immobilized on ﬂow cell
2 as the captured molecule. 50-biotinylated DNA (50-CTC
TCCTTTCTTTTTCTTCTTCCCTCCCTA-30) analogous
to the above RNA sequence was also obtained from
Dharmacon and immobilized on ﬂow cell 3 as the
captured molecule. For comparison of aCP1–KH1
binding to a series of tetrad DNA target sites, the follow-
ing 50-biotinylated sequences were purchased from
Geneworks Australia: (50-AAAAAATCCA-30;5 0-AAAA
AACTCA-30;5 0-AAAAAACCTA-30;5 0-AAAAAACCC
A-30;5 0-AAAAACCCCA-30).
The ﬁrst ﬂow cell coated with only streptavidin was
used as the reference surface. The immobilization steps
were carried out at a ﬂow rate of 10ml/min in immobiliza-
tion buffer 10mM Tris–HCl (pH 7.4), 150mM NaCl,
0.5% Triton X (or 0.025% P20) and 1–2mM
dithiothreitol, 2mM EDTA and ﬁnally blocked with
1mM Biotin in HEPES buffered saline (HBS) at 10ml/
min for 3min. An average of 30RU of oligonucleotide
was immobilized. aCP-KH domains were injected over
ﬂow cells 1–3 at a range of concentrations from
50–0.3mM using a ﬂow rate of 50ml/min and at room tem-
perature in running buffer 10mM Tris–HCl (pH 7.4),
150mM NaCl, 0.5% Triton X (or 0.025% P20) and
1–2mM dithiothreitol, 2mM EDTA, 66–125mg/ml
tRNA and 62.5mg/ml bovine serum albumin. All experi-
ments were replicated (duplicate or triplicate) to conﬁrm
the reproducibility of the signal. Regeneration involved
removal of the bound protein from the streptavidin chip
with a 1–2min wash at 20–50ml/min with 2M NaCl.
Data were analysed with the BIAevaluation software to
obtain a binding constant using a steady state model.
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The DNA ‘11-mer’ sequence 50-TTCCCTCCCTA-30
analogous to nucleotides 3315–3325 of AR mRNA, was
purchased from Dharmacon in crude form and further
puriﬁed by denaturing PAGE. After the separation of
the sample by 20% PAGE, the band was visualized by
UV shadowing when the DNA had run approximately
half way down the gel. The sample was recovered by
excising the band, which was then crushed and eluted
overnight in 0.3M sterile sodium acetate at 37 C. The
eluent was ﬁltered and desalted using a reverse-phase
solid-extraction cartridge (C18 Sepak cartridge, Waters).
The eluted fractions were lyophilized and dissolved in dis-
tilled water for quantiﬁcation using UV spectroscopy. The
DNA ‘6-mer’ sequence 50-ACCCCA-30 was purchased
from Geneworks Australia in puriﬁed form and
resolubilized in water without further puriﬁcation steps.
DNA concentrations were determined by measuring the
absorbance at 260nm and assuming one absorbance unit
to be equivalent to 34mg/ml.
Preparation of aCP1–KH1/DNA complexes for
co-crystallization
DNA and protein complexes were prepared by dissolving
the lyophilized DNA with the protein solution to a ﬁnal
molar ratio of 1:1. The mixture was left on ice for 30min
prior to setting crystal drops. Crystals were grown using
vapour diffusion in 1ml hanging drops containing 1:1
mixtures of protein and reservoir solutions. The aCP1–
KH1/11-mer complex solution contained 309mMo f
protein and DNA in 50mM Tris–HCL pH 8.0, 1mM
DTT, 1mM EDTA, 150mM NaCl, and the reservoir
solution was composed of 0.1M Na cacodylate pH 6.5
in 0.2M magnesium acetate, 30% MPD (2-methyl-2,4-
pentanediol) Sigma Crystal Screen reagent formulation
number 21. Crystals typically grew in 2 months to dimen-
sions of  0.2 0.2 0.04mm with the outline of a
diamond. The aCP1–KH1.W.C54S/6-mer were produced
using 0.1M phosphate–citrate pH 4.2, 40%(v/v) PEG 300
as the precipitant as reported (36).
X-Ray data collection, structure determination and
reﬁnement of aCP1–KH1/DNA complexes
Data for the aCP1–KH1/11-mer complex were recorded
in-house using a Rigaku RUH2R X-ray source with a
rotating copper anode equipped with Osmic confocal
optics, a MAR Research MAR345 detector and an
Oxford cryosystems 600 series cryostream from a single
crystal. The diffraction measurements indicated that the
space group was P21 with unit cell constants a=45.6,
b=76.8, c=61.4A ˚ and  =111.7  and diffraction was
recorded to 3.0A ˚ resolution. Data were integrated and
scaled with DENZO and SCALEPACK (37). Structure
factor amplitudes were calculated using TRUNCATE
(38). The data collection statistics are given in Table 1.
Initial phases were derived by molecular replacement
using the protein coordinates from the Nova2-KH3/
RNA structure (pdb accession code: 1EC6) as a search
model. The search model included residues 4–76 with the
oligonucleotide and solvent molecules removed. The pro-
gramme PHASER (39) was used to locate four molecules
in the asymmetric unit. Electron density derived from the
initial set of phases revealed the positions of the two mol-
ecules of DNA in addition to the four KH domains in the
asymmetric unit. The protein and oligonucleotide were
built using COOT (40). To aid in interpretation of the
initial electron density maps, 4-fold non-crystallographic
symmetry averaging was applied by the programme
DM (38). Tight non-crystallographic symmetry con-
straints were maintained throughout the reﬁnement.
Translation libration screw (TLS) reﬁnement was also
utilized. The reﬁnement statistics are reported in Table 1
and the atomic coordinates are available from the Protein
data bank (PDB code: 1ZTG).
The data collection for the aCP1-KH1.W.C54S/6-mer
complex is described previously (36). The structure was
solved by molecular replacement using PHASER (39)
included in the CCP4 suite (38). A single copy of the poly-
peptide chain was extracted from the coordinate of aCP1–
KH1/11-mer structure and used as search model for
both rotation and translation functions. Four copies of
the protein were identiﬁed in the asymmetric unit and
the oligonucleotide was manually built in COOT (40).
Several cycles of reﬁnement were carried out using non-
crystallographic symmetry constraints in REFMAC5 (41)
and PHENIX (42). Water molecules were added by
ARP/WARP (43) and amino acids side chains were
manually checked and rebuilt in COOT. TLS reﬁnement
was also utilized. Data collection statistics are previously
reported (36) and the reﬁnement statistics are reported in
Table 1. The structure factors and the coordinate of the
ﬁnal model are available in the protein data bank (PDB
code: 3VKE).
RESULTS
Multimeric RNA complexes are formed by full-length
aCP1, but not aCP1–KH1 alone
aCP1 has been shown to bind in a sequence-speciﬁc
manner to a UC-rich region, located in the 30-UTR of
androgen receptor mRNA (nucleotides 3275–3325), that
is implicated in the regulation of AR mRNA stability
and translational efﬁciency (35). We have previously
shown that aCP1–KH3 independently binds this
sequence and that aCP1–KH2 does not using EMSA
(44). In the current study, we examine the binding of
this AR mRNA sequence by full-length aCP1 and
aCP1–KH1.
The binding of full-length aCP1 to the target 51-nt AR
mRNA sequence in an EMSA experiment is shown in
Figure 1A. The probe (10nM RNA) is shifted upon the
addition of increasing concentrations of aCP1 (10nM–
1mM), with half of the probe shifted when between 20
and 50nM, aCP1 is added. This is consistent with a
previous report of a KD in thenM range (35). Notably,
full-length aCP1 shifts the probe to positions that increase
in size with aCP1 concentration revealing the forma-
tion of higher molecular weight complexes. Binding by
5104 Nucleic Acids Research, 2012,Vol.40, No. 11aCP1–KH1 to the target RNA is also shown in Figure 1A.
The single KH domain shifts the target RNA (likely via a
2:1 protein:RNA binding stoichiometry) to a discrete
position showing that full-length aCP1, but not aCP1–
KH1 alone, forms large multimeric complexes with RNA.
Full-length aCP1 and aCP1–KH1 bind to target RNA, as
well as DNA
The ‘CCCUCCC’ motif at the 30-end of the target 51-nt
AR mRNA has been shown to be the binding site of aCP
proteins through mutational analysis of the two poly(C)
triads (35). In order to verify whether full-length aCP1
and aCP1–KH1 binding occurs to this motif in vitro,w e
conducted gel shift assays using an 11-nt probe corres-
ponding to nucleotides 3315–3325 of AR mRNA (50-UU
CCCUCCCUA-30). Figure 1B shows that the probe is
shifted by full-length protein to a constant position,
indicating good binding to the probe via a single binding
interaction. aCP1–KH1 also binds, but only marginally
shifts the probe under the conditions of this experiment,
indicating a weaker interaction. Interestingly, the binding
proﬁles of aCP1 and aCP1–KH1 to an 11-nt DNA probe
analogous to the AR target sequence above (DNA: 50-TT
CCCTCCCTA-30) are very similar to the binding observed
to RNA (Figure 1B). Full-length aCP1 and aCP1–KH1
bind to the DNA with good and weak binding respect-
ively. Notably, the binding of full-length aCP1 appears to
shift more of the DNA probe than the RNA probe, sug-
gesting a marginally higher afﬁnity for DNA over RNA.
aCP1–KH1 forms the most stable interactions to a C-rich
RNA and DNA
Having shown that aCP1–KH1 binds to both DNA and
RNA using EMSA, we utilized SPR for a more sensitive
comparison of KH domain binding afﬁnities and binding
kinetics to target RNA and the analogous DNA sequence.
SPR binding curves showing a series of aCP1–KH inter-
actions (at concentrations of between 0.312mM and
10mM) with a 30-nt oligonucleotide representing AR
mRNA (nucleotides 3296–3325) are shown in Figure 2.
This RNA sequence includes 19-nt of U-rich sequence
preceding the 11-nt C-rich target sequence (as used in
the EMSA above) as a spacer between the Biacore chip
and the binding site. Alongside these curves are the
sensorgrams obtained simultaneously using the analogous
sequence of DNA. It is to be noted that the binding curves
exhibited complex binding kinetics, most likely due to the
lengthy oligonucleotides immobilized on the chip and the
presence of two cytosine triplets at the 30-ends that con-
stitute two aCP1–KH domain target sites. Where binding
was observed, an approximated steady state binding
analysis is presented.
aCP1–KH1 was found to readily associate with the
RNA and a slow dissociation phase was observed,
Table 1. Statistics for X-ray crystallographic data collection and reﬁnement
aCP1–KH1/11-mer aCP1–KH1.W.C54S/6-mer
Data collection
a
Space group P21 P21
Cell dimensions
a, b, c (A ˚ ) 45.6, 76.8, 61.4 38.6, 114.9, 43.4
abg ( ) 90.0, 111.7, 90.0 90.0, 93.4, 90.0
Resolution (A ˚ ) 30.0 – 3.0 (3.11 – 3.0) 30.0 – 1.77 (1.87 – 1.77)
Rmerge
b(%) 5.7 (65.8) 9.0 (60.2)
I/s(I) 22.7 (2.1) 7.9 (2.2)
Reﬂections measured (total) 35603 (394) 113451 (16460)
Completeness (%) 99.8 (99.9) 99.7 (100)
Redundancy 4.4 (4.0) 3.2 (3.1)
Reﬁnement
Resolution (A ˚ ) 3.0 1.77
No. of reﬂections used (unique) 7994 34271
Rwork/Rfree 23.0 / 27.9 16.4 / 21.3
No. of atoms
Protein 2193 2281
Oligonucleotide 308 392
Water 71
B-factors (A ˚ 2)
Protein 79.2 30.4
Oligonucleotide 91.5 34.3
Water 43.1
RMS deviations
Bond lengths (A ˚ ) 0.007 0.027
Bond angles ( ) 1.164 2.243
Ramachandran plot
c (%)
Favoured regions 95.3 98.9
The statistics for both the aCP1–KH1/11-mer and aCP1–KH1.W.C54S/6-mer structures are shown.
aValues in parentheses refer to the highest resolution shell.
bRmerge=
P
jI <I>j/
P
<I> where I is the intensity of individual reﬂections.
cDetermined using the program MOLPROBITY(45).
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equilibrium constant (KD) calculated from a steady state
analysis was estimated to be 3.6±0.6mM. In the case of
aCP-KH1 binding to DNA, a relatively slow dissociation
was also observed and the KD was determined to be
0.33±0.04mM, representing  10-fold increase in
afﬁnity of aCP1–KH1 for DNA over RNA.
The interactions of aCP1–KH2 with target RNA and
DNA were also examined for comparison. The aCP1–
KH2 domain has not previously been shown to be able
to independently bind to RNA (32,44). Consistent with
these reports, no binding interaction was detectable
between aCP1–KH2 and RNA even at the highest
protein concentrations. However, we detected binding to
DNA, albeit with a low response. A steady state analysis
of the aCP1–KH2 interaction with DNA yielded a KD of
13±4mM. This indicates that a functional aCP1–KH2
was formed, but that interactions with RNA could not
be detected.
In contrast, aCP1–KH3 bound to both RNA and DNA
with similar afﬁnities to aCP1–KH1. Dissociation equilib-
rium constants calculated from a steady state analysis
were KD=3.5±0.8mM and KD=1.5±0.2mM, respect-
ively. The complex half-life of aCP1–KH3 with DNA and
RNA, however, were shorter than that for aCP1–KH1,
with response curves returning to the baseline promptly
at the end of the protein injection phase.
Thus, oligonucleotide binding could be measured for all
three individual aCP1–KH domains with the exception of
KH2 binding to RNA. KH1 engages in the most stable
interaction with both RNA and DNA of the three KH
domains. KH2 and KH3 are also both capable of
binding DNA.
Structural overview of aCP1–KH1 bound to adjacent
CCCT binding sites
In order to examine the structural basis for the differences
in KH domain interactions with target oligonucleotide,
crystal trials were undertaken with each of the three
aCP1–KH domains in complex with the DNA sequence
50-TTCCCTCCCTA-30 (analogous to nucleotides 3315–
3325 of AR mRNA). Only aCP1–KH1 yielded crystals,
which was not unexpected considering that KH1 forms the
most stable complexes with DNA. aCP1–KH1 (residues
14–86, numbered as in Swiss-Prot entry Q15365, preceded
by the sequence GPLGSPGI present due to cloning pro-
cedures) yielded crystals containing two crystallographic-
ally independent copies of a 2:1 protein–DNA complex in
the asymmetric unit. Equivalent crystallization experi-
ments utilizing RNA did not produce crystals suitable
for structure determination. Experimental phases were
obtained by molecular replacement using coordinates
from the Nova2-KH3 structure (PDB ID:1EC6) with the
oligonucleotide removed. The current reﬁnement model
has a working R-factor of 23.0% and a free R-value of
27.9% at 3.0A ˚ resolution (Table 1), with good stereo-
chemistry 95% in the favoured regions of a
Ramachandran plot (100% in the allowed regions). The
coordinates are deposited in the protein structure database
(pdb id:1ZTG).
The aCP1–KH1/11-mer structure reveals two aCP1–
KH1 domains bound at adjacent CCCT sequences
(Figure 3A). The ﬁnal model deﬁned the position of
residues 13–83 of aCP1–KH1 and the four bound bases
in each of the binding clefts. Although the two KH
domains bound to the same oligonucleotide are held
very closely, they do not make contact with one another
(Figure 3A). Interestingly, in this crystal form, each KH1
domain is covalently linked to an adjacent KH1 domain
by a disulphide bond formed through their C54 residues.
Furthermore, each KH domain exists as a dimer with a
KH domain from an adjacent unit as previously observed
for other KH domain structures (26,27,30,31).
The protein conforms to the classical type I KH domain
structure, with a three-stranded anti-parallel b-sheet
A
B
[αCP1-KH1] [αCP1]
slot-
free -
probe
slot-
free -
probe
RNA DNA
(-) (-)
[αCP1] [KH1] [αCP1] [KH1]
Figure 1. Binding of aCP1 and aCP1–KH1 to oligonucleotides repre-
senting the UC-rich region of androgen receptor 30-UTR. (A)A
mobility shift assay, run on a 5% PAA/0.5 TBE gel is shown.
50-end labelled RNA was incubated either alone ( ) or in the
presence of puriﬁed aCP1 or aCP1–KH1 as indicated above the gel.
The probe comprises a total of 107-nt RNA containing vector se-
quences and nucleotides 3275–3325 of the androgen receptor mRNA.
Increasing protein concentrations are indicated by a wedge and are,
from the left: 1 10
 8M, 2 10
 8M, 5 10
 8M, 1 10
 7M,
2 10
 7M, 5 10
 7Mo r1  10
 6M for both proteins. In all cases,
RNA concentration is 1 10
 8M. All lanes also contained 1mg yeast
tRNA added as a non-speciﬁc competitor. (B) A mobility shift assay,
run on a 10% PAA/0.5 TBE gel is shown. 50 =-end labelled 11-mer
RNA or DNA was incubated either alone ( ) or in the presence of
puriﬁed aCP1 or aCP1–KH1 as indicated above the gel. Probe se-
quences are: RNA: 50-UUCCCUCCCUA; DNA: 50-TTCCC
TCCCTA. Increasing protein concentrations are indicated by a wedge
and are, from the left: for aCP 1, 1 10
 7M, 3 10
 7M and
1 10
 6M; for aCP1–KH1, 1 10
 6M, 3 10
 6M and 1 10
 5M.
In all cases, RNA or DNA concentration is 1 10
 7M. All lanes
also contained 1mg yeast tRNA added as a non-speciﬁc competitor.
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arrangement (Figure 3B). The structure is consistent
with that reported for the aCP2-KH1 homologue bound
to a telomeric DNA sequence solved to 1.7A ˚ resolution
[pdb id: 2AXY; identity 97% and Ca pair-wise root mean
square deviation (RMSD) 1.1A ˚ ] (31). A hydrophobic core
provides the structure’s stability, with hydrophobic
residues emanating from the inner face of the b-sheet
(including Leu14, Ile16, Leu18, Met20, Ala45, Ile47,
Ile49, Ile59 and Leu61) and all three helices (including
Glu24, Val25, Ile28, Val36, Ile39, Arg40, Ala67, Ile68,
Ala71, Ile75, Lys78 and Leu79). This core is partly
exposed to create the base of the hydrophobic oligo-
nucleotide binding cleft.
The dimer interface is formed via an anti-parallel inter-
action between the third a-helices of paired aCP1–KH1
domains via hydrophobic interactions including a ring
stacking arrangement of Phe72 side chain aromatic
rings. This interaction also brings together the ﬁrst
b-strand of each aCP1–KH1 domain to effectively form
a continuous six-stranded anti-parallel b-sheet, though the
two strands are only connected via backbone hydrogen
bonds between Arg17 NH and Leu19 CO of respective
KH domains. Additional inter-molecular hydrogen bond
interactions are made from the Arg17 side chain
guanidinium to both the Leu19 backbone carbonyl and
Glu24 side chain carboxylic acid groups of the opposing
aCP1–KH1 domain and from the Glu80 side chain to the
Thr65 side chain hydroxyl of the opposing aCP1–KH1
domains.
The oligonucleotide is accommodated in a hydrophobic
cleft formed across the top of a-helix 1 and bounded by
the ‘GXXG’ motif and variable loop (Figure 3B). The
DNA binding cleft is on the opposite side of the
molecule to the dimerization interface so that both inter-
actions can occur simultaneously. Basic residues sur-
rounding the binding site, including Lys 23, Lysines 31
and 32 at the ‘XX’ positions, Lys37 and Arginines 40,
46 and 57, create a positive potential along the length of
the cleft (Figure 3C). Such a potential, similarly observed
for aCP1–KH3 (28), likely provides a driving force for the
docking of the oligonucleotide to the site, and also
provides speciﬁc electrostatic contacts to the bound oligo-
nucleotide. The two aCP1–KH1 monomers bound to the
11-base oligonucleotide make equivalent contacts to se-
quential ‘CCCT’ tetrads, so that the two monomers are
arranged in a tail to head arrangement on the DNA. The
oligonucleotide is arranged in a linear fashion with bases
arranged planar to the surface of the protein except for
Thy-4 of each tetrad that partially base stacks over Cyt-3.
Only a single intra-molecular hydrogen bond between
Cyt-2 N4 of the ﬁrst (50) tetrad and the phosphate
Figure 2. Binding analysis of separate KH domains of aCP1 to target RNA and DNA using SPR. Sensorgrams of aCP1 KH1, KH2 and KH3
binding to biotinylated mRNA (50-CUCUCCUUUCUUUUUCUUCUUCCCUCCCUA-30) representing nucleotides 3296–3325 of androgen
receptor mRNA (ﬂow cell 2) and biotinylated DNA (50-CTCTCCTTTCTTTTTCTTCTTCCCTCCCTA-30) analogous to the above RNA
sequence (ﬂow cell 3) captured on SA-coated sensor chips at a range of protein concentrations are shown. Binding curves, derived from the
approximated steady state binding of the proteins, were used to determine equilibrum dissociation constants (KDs). Errors are standard errors
arising from ﬁts.
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about the phosphate bond of the fourth base to allow
the second KH1 monomer to bind downstream of
the ﬁrst site  180  about the oligonucleotide axis
(Figure 3A). Similarly to reports of other KH domains
bound to DNA with multiple binding sites (26,30), this
shows the way in which two KH domains may be
closely juxtaposed when bound at adjacent C-rich
binding sites.
Binding speciﬁcity of aCP1–KH1 for cytosines in the
CCCT tetrad
Of particular interest in this study, was the determination
of the inter-molecular contacts underlying cytosine speciﬁ-
city. The aCP1–KH1/11-mer interactions are summarized
in Figure 3D. As seen for isoform aCP2-KH1 (30), the
central two cytosines of the bound tetrad (Cyt-2 and
Cyt-3) engage in hydrogen bond interactions that form
the basis for cytosine speciﬁcity at these positions. The
cytosine in the second position forms van der Waals
contacts with Val25, Gly26 and Ile29. The basis for
cytosine speciﬁcity in this position is dominated by
interactions with Arg57 which projects from the variable
loop region and forms bipartite hydrogen bonds to Cyt-2
O2 and N3 atoms. In addition, the backbone carbonyl of
Gly22 is able to form a hydrogen bond with Cyt-2 N4.
The cytosine in the third position (Cyt-3) is positioned
over hydrophobic residues Ile29, Ile49 and Val36.
Binding speciﬁcity for Cyt-3 is conferred by Ile49 and
Arg40 which are conservatively substituted and conserved
respectively in poly(C)-binding proteins. The backbone
carbonyl of Ile49 is positioned to form a hydrogen bond
with Cyt-3 N4. Arg40 extends from the C-terminal end of
a-helix 2 and is able to make hydrogen-bond contact with
the Cyt-3 O2 atom.
Unlike previous studies, this structure also reveals
possible interactions underlying base speciﬁcity at pos-
itions 1 and 4. Cyt-1, in the ﬁrst position, forms a
hydrogen bond with the side chain of Asp82 via its N4
group. In addition, non-speciﬁc interactions between
Cyt-1 and Gly26, Ser27, Gly30 and Lys31 backbone
atoms, that form part of the oligonucleotide binding
cleft, are also observed. Thy-4 is not extensively contacted
by the KH domain. It forms base stacking interactions
Figure 3. Schematic representations of the aCP1–KH1/11-mer DNA complex. (A) aCP1–KH1 formed as a dimer with two protein molecules bound
to a single 11-nt strand of DNA, resulting in a continuous network throughout the crystal. (B) A cartoon representation of the KH domain bound to
the target DNA. The 50-tetrad of the target DNA that form contacts with the ﬁrst KH domain is shown, illustrating the positioning of the critical
bases about a-helix 1 and between the GXXG and variable loops. (C) The electrostatic potential emanating from the aCP1–KH1 (in the same
orientation as cartoon alongside) structure calculated using the APBS software package (46). Potential contours are shown at +1kT/e (blue) and
 1kT/e (red) and were obtained by solution of the linearized Poisson–Boltzmann equation at 150mM ionic strength with a solute dielectric of 2 and
a solvent dielectric of 78.5. The blue contour represents a positive potential directing oligonucleotides to the binding cleft. (D) Summary of the
contacts between aCP1–KH1 and bound DNA tetrad of sequence 50-CCCT-30. Van der Waals contacts are coloured orange, and hydrogen bond
interactions are coloured blue. The residues making important contacts with the oligonucleotide sugar–phosphate backbone are listed on the left, and
the residues making contacts with the pyrimidine rings, and thus underling base speciﬁcity, are listed on the right.
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However, Arg40 is positioned such that its guanidinium
nitrogens are positioned to form hydrogen bonds with
both Thy-4 and Cyt-3 O2 groups. Such an interaction
could favour either thymine or cytosine at position 4.
Cytosine is preferentially bound by aCP1–KH1 at all four
base positions
In previous studies of aCP-KH1 domains, it has been
shown that the ﬁrst position in the oligonucleotide
binding cleft can accommodate an A, T or C, with little
to indicate a preferred base at this position (30,31). The
fourth position has been shown to accommodate T or C,
but not a purine base. Yet, systematic evolution of ligand
by exponential enrichment (SELEX) studies originally
performed to characterize the aCP target sequence
clearly identiﬁed sequences containing C-triplets and
tetrads (33).
To investigate the position-speciﬁc binding preferences
of aCP1–KH1, we used SPR to monitor binding to a
series of oligonuceotides in which cytosines were system-
atically replaced by adenine or thymine. Figure 4 shows
sensorgrams of aCP1–KH1 binding to different 10-mer
DNA containing oligonucelotide target tetrads and the
steady state binding analysis in the cases where quantiﬁ-
able binding was measured. A 5-nt A-rich spacer was
included at the 50-end of the oligonucleotide to distance
the binding site from the matrix surface and another
adenine was added at the 30-end to restrict the possible
binding mode to the target tetrad since purines have not
been observed to bind at the fourth position. By this rea-
soning, we could assume that the target tetrad (underlined
in each of the sequences) would be bound in the same
register at the aCP1–KH1 binding site.
The ﬁrst experiment was conducted with the sequence
50-AAAAAACCCA-30. The binding to this short single
binding site DNA sequence occurred with a fast off-rate
compared with the slow off-rate observed in the previous
experiments, and readily reached equilibrium. Binding by
aCP1–KH1 to this oligonucleotide was found to occur
with micromolar afﬁnity (KD=33mM). The second ex-
periment, in comparison with the ﬁrst, shows that
cytosine in position 2 is important for binding. The
sequence 50-AAAAAATCCA-30 (in which Cyt-2 is
replaced by thymine) showed no binding by aCP1–KH1.
This experiment also conﬁrmed the assumption that
adenine cannot be accommodated in position 4 (since, if
it could, there would be no impediment to TCC binding in
positions 1, 2 and 3). The non-binding of the ATCC
sequence then, demonstrates the critical role of cytosine
at position 2. Likewise, in the third experiment, the
sequence 50-AAAAAACTCA-30 (in which Cyt-3 is
replaced) showed no binding by aCP1–KH1. By the
same logic, this conﬁrms the critical role of cytosine in
position 3. In contrast, the fourth experiment shows that
cytosine is preferred, but not essential, in the fourth
position. The sequence 50-AAAAAACCTA-30 (in which
the Cyt-4 is replaced), showed some binding (though not
quantiﬁable). The binding was reduced compared with the
oligonucleotide containing a C-triplet, and therefore,
shows that a thymine is tolerated in position 4, though
cytosine is preferred. Last, the sequence 50-AAAAA
CCCCA-30 containing a C-rich tetrad was bound by
aCP1–KH1 with 10-fold higher afﬁnity (KD=3.5mM)
than the ACCC sequence. This enhanced binding
suggests that, in fact, a cytosine is preferred over
adenine in the ﬁrst position. From this series of experi-
ments, it was established that in fact, there is a binding
preference for cytosine by aCP1–KH1 at positions 1 and 4
(as well as 2 and 3).
High resolution structure aCP1–KH1.W.C54S bound to
a CCCC tetrad
In order to obtain higher resolution structural data for the
aCP1–KH1/DNA complex, we strategically designed
Figure 4. Binding analysis of aCP1–KH domains of aCP1 to target
RNA and DNA using SPR. Sensorgrams of aCP1–KH1 binding to a
series of biotinylated DNA sequences, designed to test the preferential
binding of cytosine at each of the four nucleotide binding positions.
The sequences are shown above each set of sensorgrams with the
binding tetrad underlined. Five adenines were used as a spacer
between the biotin and the oligonucleotide binding site.
Oligonucletides were captured on SA-coated sensor chips at a range
of protein concentrations. Binding curves, derived from the
approximated steady state binding of the proteins, were used to deter-
mine equilibrum dissociation constants (KDs). Errors are standard
errors arising from ﬁts.
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Having recognized the tendency of C54 to form
inter-molecular disulphide bonds upon crystallization,
we prepared a C54S aCP-KH1 mutant and also added a
tryptophan to the C-terminus to facilitate detection at
280nm that would assist with puriﬁcation. This construct,
referred to as aCP1-KH1.W.C54S formed high quality
crystals in complex with a C-tetrad DNA sequence 50-A
CCCCA-30 established by our binding studies as a high
afﬁnity ligand. The crystals were grown as reported and
diffracted to 1.77A ˚ resolution (36). The structure was
solved by molecular replacement using the coordinates
of a monomer from the aCP1–KH1/11-mer DNA
complex as starting model (pdb id: 1ZTG). The oligo-
nucleotide was removed from the coordinate prior to cal-
culation. The reﬁned model has a working R-factor of
16.35% and a free R-value of 21.34% at 1.77A ˚ resolution
with an excellent stereochemistry including 99% of all
amino acids in the favoured regions of a Ramachandran
plot (100% in the allowed regions) (Table 1). As indicated
in the coordinate ﬁle, the ﬁnal model includes residues
14–86 of aCP1 and supplementary residues due to
cloning procedures at N- and C-terminus. The coordinates
are deposited in the protein structure data base (pdb
id:3VKE).
The aCP1-KH1.W.C54S/6-mer structure reveals the
same organization as that described above for the
aCP1-KH1/11-mer structure (Ca pair-wise RMSD
0.395A ˚ ), establishing that the W and C54S mutations
do not affect the structure or binding of oligonucleotide.
The asymmetric unit contains four monomers organized
as a pair of dimers. Each monomer binds a single copy of
the 6-mer DNA. The position of 6nt out of 6 was clearly
identiﬁed in two chains in the electron density map (Figure
5A). In the two remaining chains, only the central four
nucleotides are present. Absence of the extreme nucleo-
tides can be attributed to a crystallization artefact, since
those positions coincide with the crystallographic 2-fold
screw axis. The oligonucleotide is arranged in an analo-
gous fashion to that observed for the aCP1–KH1/11-mer
DNA. In this case though, as well as partial base stacking
of Cyt-4 across Cyt-3, base stacking is also observed for
the terminal adenosine bases. Interestingly, an
intra-molecular hydrogen bond is formed between Cyt-2
N4 and the phosphate preceding Cyt-1, as also seen for the
aCP1–KH1/11-mer DNA. In addition, an equivalent
hydrogen bond is formed between Cyt-4 N4 and the phos-
phate preceding Cyt-3. Such hydrogen bonds, that are
uniquely formed by cytosine, may help to stabilize the
bound oligonucleotide conformation.
Cytosine recognition at all four nucleotide
binding positions
The four cytosines are positioned in the hydrophobic
binding cleft in similar positions as seen for the CCCT
sequence in the aCP1–KH1/11-mer structure (Figure
5B). The aCP1–KH1.W.C54S/6-mer interactions are
summarized in Figure 5C and D. The central two cyto-
sines of the tetrad (Cyt-2 and Cyt-3) are positioned analo-
gously to that previously described. Speciﬁc contacts to
Cyt-2 are made via hydrogen bond interactions with the
Arg57 guanidinium side chain and Gly22 backbone
oxygen groups. Speciﬁc contacts to Cyt-3 are made via
hydrogen bonds with the Arg40 guanidinium side chain
and the backbone carbonyl of Ile49.
In addition to these contacts underlying speciﬁcity at
positions 2 and 3, the aCP1–KH1.W.C54S/6-mer struc-
ture revealed further contacts that underlie a preference
for cytosine in position 1, as well as the hydrogen bond
between the side chain of Asp82 and the Cyt-1 N4 group,
a hydrogen bond is also seen between the Lys31 backbone
NH and the Cyt-1 O2 group. In the case of Cyt-4, a clear
difference is seen from the aCP1–KH1/11-mer structure in
which thymine was present at this position. The side chain
of Glu51, that was not positioned towards the oligo-
nucleotide in the aCP1–KH1/11-mer structure is clearly
deﬁned in the density of the aCP1–KH1.W.C54S/6-mer
structure and forms a hydrogen bond to the Cyt-4 N4
group. Together, these favourable and speciﬁc interactions
likely contribute towards the higher afﬁnity of a C-tetrad
at the binding site of aCP1–KH1.
Interestingly, the 50-Ade also makes contact with the
aCP1–KH1 binding cleft in the aCP1–KH1.W.C54S/
6-mer structure. It forms base stacking interactions with
Cyt-1 and also is able to form hydrogen bonds with the
Ser85 side chain hydroxyl. Ser85 was not positioned to
interact with the oligonucleotide in the aCP1–KH1/
11-mer structure, suggesting that an additional interaction
with adenine, not previously detected, to our knowledge,
in the study of KH domains, may play a role in the
binding of aCP1–KH1 to target oligonucleotides. In
contrast, the 30-Ade forms base stacking interactions
with Cyt-4 and is held away from the surface of the
protein where it does not make direct protein interactions.
DISCUSSION
PCBP are triple KH domain proteins that exert an extra-
ordinarily diverse array of functions through their ability
to interact with C-rich single stranded oligonucleotides.
This includes the stabilization of mRNA, translational
repression, translational enhancement, transcriptional
enhancement and possible involvement in telomere func-
tioning. This functional diversity suggests that PCBP do
not confer a speciﬁc functional outcome, but may play a
general scaffolding role and help to form a variety of func-
tional oligonucleotide structures, depending upon the
target C-rich sequence. Such a role could be achieved via
the interactions of the individual KH domains of PCBP
with adjacent C-rich regions of the target oligonucleotide,
and also through intra- and/or inter-molecular interactions
between PCBP and other RNA-binding proteins.
In the current study, we focus on the PCBP aCP1 (also
known as PCBP1 and hnRNP E1). In the previous work,
we identiﬁed aCP1 as one of the proteins that targets the
androgen receptor (AR) mRNA at a speciﬁc 30-UTR site,
and plays a role in the regulation of its translation (35). In
an effort to better understand the mode of interaction of
aCP1 with this mRNA target, we ﬁrst undertook EMSA
experiments with the 51-nt target (representing AR
5110 Nucleic Acids Research, 2012,Vol.40, No. 11mRNA nucleotides 3275–3325). This showed not only an
interaction, but the formation of increasingly large
multimeric structures as higher proportions of aCP1
were added. This suggests that either aCP1 is capable of
binding the target RNA at multiple sites at high concen-
trations (i.e. not only at the C-rich site) or that aCP1 can
initiate the formation of multi-protein/RNA complexes.
Since aCP1–KH1 alone was also able to shift the probe,
but did not cause increasingly large structures to be
formed, it suggests that the triple KH motif structure of
full-length aCP1 facilitates the formation of multi-protein/
RNA complexes. This is most likely to represent a
function of the dimerizing ability of KH domains 1 and
2 that have been identiﬁed as forming intra-molecular
homodimer, but could play a role in inter-molecular
heterodimerization (30).
Through further EMSA studies focusing on the speciﬁc
11-nt C-rich site of AR mRNA and its DNA equivalent
sequence, we conﬁrmed that aCP1 could interact with
both oligonucleotides. aCP1–KH1 alone could also shift
these probes, though did not bind with as high afﬁnity as
the full-length protein. Thus, the interaction of full-length
aCP1 with RNA and DNA is supported by its multiple
KH domain interactions. Furthermore, it appeared from
these experiments that DNA was more readily shifted than
RNA, implying a higher afﬁnity interaction with DNA.
This would be in contrast to a previous report of higher
afﬁnity binding by aCP proteins to RNA over DNA (32).
In their report, however, binding to poly-C-RNA was
being compared with binding to a ssDNA corresponding
to the sequence from the V8 domain from human riboso-
mal RNA, i.e. a long GC-rich sequence that may not have
availed the equivalent density of C-rich target sites. This
study, in contrast, utilized directly equivalent RNA and
DNA. The moderately higher binding afﬁnity to DNA
over RNA in vitro likely reﬂects the greater structural ac-
cessibility of the DNA (due to the absence of the sugar
20-OH that assists RNA secondary structure formation)
for forming productive binding interactions. Within the
cell, however, the actual target of aCPs will be dictated
by the localization of the protein and the accessibility of
single-stranded C-rich regions of the oligonucleotides,
rather than be a function of the difference in afﬁnity.
In order to more quantitatively deﬁne the roles of the
three individual aCP1 KH domains in interacting with
RNA and DNA, SPR studies were carried out with each
of the individual KH domains. The binding afﬁnities of
the individual KH domains were in the micro-molar
Figure 5. Schematic representations of the aCP1–KH1/6-mer DNA complex. (A) aCP1–KH1.W.C54S is shown in cartoon representation with the
electron density (blue mesh representation) surrounding the bound oligonucleotide (stick representation) showing the well resolved positioning of the
oligonucleotide. (B) The surface of the aCP1–KH1.W.C54S structure is shown in grey illustrating the binding cleft that accommodates the oligo-
nucleotide (stick representation). (C) Summary of the contacts between aCP1–KH1.W.C54S and bound DNA of sequence 50-ACCCCA-30. Van der
Waals contacts are coloured orange, and hydrogen bond interactions are coloured blue. The residues making important contacts with the oligo-
nucleotide sugar–phosphate backbone are listed on the left, and the residues making contacts with the pyrimidine rings, and thus underling base
speciﬁcity, are listed on the right. (D) Cartoon view of each of the four cytosines of the C-tetrad (stick representations) within the binding cleft of
aCP1–KH1.W.C54S (cartoon representation and transparent surface). Key interacting residues are coloured in orange and hydrogen bonds
underlying speciﬁcity are shown in black.
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for full-length aCP-KH1 to target AR mRNA (35). The
KH domains thus act synergistically to achieve tighter
binding by several orders of magnitude over their individ-
ual binding. A comparison of KH domain binding inter-
actions revealed that aCP1–KH1 and KH3 contribute the
most to the binding afﬁnity of aCP1 to the C-rich oligo-
nucleotide, with a slow dissociation phase observed for
KH1 indicating the most stable interaction. Interestingly,
whereas interactions between KH2 and RNA could not be
detected, KH2 binding to DNA was observed.
Furthermore, for all three aCP1 KH domains, higher
afﬁnities were again observed for DNA over RNA. This
was not a reﬂection of different protein preparations, as
experiments were conducted simultaneously (with RNA
and DNA on individual ﬂow cells of the same chip).
Overall, it is evident that KH1 and KH3 are likely to
make the primary interactions with target oligonucleotide,
with KH1 conferring the greatest stability to the inter-
action. Although RNA binding by KH2 was not
observed, in the context of the full-length aCP1 where it
is covalently tethered close to the RNA via KH1 and
KH3, it would have a greatly enhanced chance of
interaction.
The structure of aCP1–KH1 bound to an 11-mer with
two immediately adjacent C-rich sites provides further
insight into the topological arrangement between
poly-C-binding proteins and their target RNA or DNA.
The aCP1–KH1 domains were arranged without the for-
mation of contacts between aCP1 and KH1 domains
bound at adjacent DNA binding sites. The way in which
the aCP2-KH domains can bind in close proximity
without forming contacts has previously been shown crys-
tallographically at C-rich sites separated by 2nt (30). In
contrast, the structure of KH3 of hnRNPK bound at im-
mediately adjacent sites places the DNA tightly sand-
wiched between the two KH domains (26). Their close
proximity potentially allows interactions between the
GXXG region of one KH domain with the variable loop
region of the next. The current structure shows, however,
that it is possible for KH domains to be bound arranged
head-to-tail at immediately adjacent oligonucleotide sites
without forming contacts with one another. This may
reﬂect the way in which covalently attached KH
domains within full-length aCP1 interact with target
oligonucleotide.
Furthermore, the current structure demonstrates that
aCP1–KH1 binding to two immediately adjacent C-rich
sites can occur simultaneously with dimer formation.
Throughout the crystal lattice of the aCP1–KH1/11-mer
DNA complex was a network of protein/DNA complexes
interconnected via homo-dimer KH domain interactions.
Both homo- and heterodimer formation have previously
been observed for KH domains (26,27,30,31) and, espe-
cially within the context of the higher afﬁnity multivalent
full-length aCP1, this type of network could explain the
observation of increasing molecular weight species
observed with increasing aCP1 added to target
oligonucelotide.
In the current study, we were particularly interested to
better understand the basis for aCP1–KH1 speciﬁcity for
C-rich oligonucleotides. In previous studies of related KH
domains, it has been established that the oligonucleotide
binding cleft accommodates four nucleotide binding pos-
itions and that it is the central two positions that confer
speciﬁcity to cytosines (26–31). The structural studies
showed, however, A, T or C bound in the ﬁrst position
and C or T, but not a purine, bound in the fourth position.
In our own aCP1–KH1/11-mer structure, we observed
CCCT bound in the oligonucleotide binding site in the
same way as reported for aCP2–KH1 bound to a telo-
meric sequence containing CCCT (31). A subsequent
study by the same group however, showed that this telo-
meric sequence could also be bound by aCP2–KH1 in a
different register, with ACCC placed in the oligonucleo-
tide binding site (30). This raises the question of whether
there is, in fact, a binding preference by aCP–KH1
domains for speciﬁc bases in the ﬁrst and fourth positions.
We therefore used SPR to measure the afﬁnity of a
series of oligonucleotides in which cytosines within a
target tetrad were systematically replaced by thymine or
adenine. These experiments conﬁrmed that the presence of
cytosine at the central positions (positions 2 and 3) is es-
sential for binding by aCP1–KH1. The experiments also
showed that cytosine was preferentially bound at the
fourth position, though thymine was tolerated and inter-
estingly, that a cytosine tetrad bound with the highest
afﬁnity interactions of all. Thus for the ﬁrst time, it is
demonstated that, in fact, aCP1–KH1 domain preferen-
tially binds cytosine at all four positions of its oligonucleo-
tide binding cleft.
The structural basis for this preferential binding is
revealed in the high resolution structure of a aCP1–KH1
mutant (aCP1–KH1.W.C54S) in complex with a cytosine
tetrad DNA (50-ACCCCA-30). At position 1, the same
protein–oligonucleotide interactions as observed for
aCP2-KH1 bound to a pair of tandem ‘CCCT’ motifs
were observed (30). In the current structure, however,
we observed an interaction between Cyt-1 and the Asp82
side chain not observed for aCP2–KH1 since the aCP2–
KH1 construct stopped short of residue 82. We also
observed an interaction between Cyt-1 O2 with the
backbone NH of Lys31 that was present, but not
reported for aCP2-KH1. Both of these interactions
would favour the binding of cytosine at position 1. A
further feature of this structure is the positioning of the
nucleotide that precedes the bound tetrad. A nucleotide in
this position has not been previously reported to form
signiﬁcant interactions with a KH domain, but owing to
the few extra residues at the C-terminal end of our aCP1–
KH1.W.C54S construct we were able to observe hydrogen
bonds to the adenine base in this position. Together, these
interactions may contribute to the higher afﬁnity of the
C-tetrad observed and reveal the molecular basis for the
preferential binding of cytosine in the ﬁrst nucleotide
binding position.
With respect to the fourth position, we did not observe
any base-speciﬁc interactions to Thy-4 in the aCP1–KH1/
11-mer structure. A hydrogen bond from the Arg40
guanidinium group to the Thy-4 O2 was observed, but
this could equally well support binding to cytosine in
this position. The only reported base-speciﬁc interaction
5112 Nucleic Acids Research, 2012,Vol.40, No. 11to a base in the fourth position has been a hydrogen bond
between the Glu51 side chain and the cytosine-N4 group
(31). Indeed, this was also observed in the current aCP1–
KH1.W.C54S/6-mer structure and clearly supports
speciﬁc binding to cytosine. A further feature of cytosine
in this position, however, is the intra-molecular hydrogen
bond that is formed between the Cyt-4 N4 group and the
phosphate linking Cyt-3 and Cyt-4. This interaction, that
thymine does not form, may contribute to the overall pref-
erential binding of cytosine though the stabilization of the
bound oligonucleotide conformation.
Thus, together these data demonstrate that aCP1–KH1
preferentially binds a C-rich tetrad and reveal the molecu-
lar basis for this speciﬁcity. In the context of the
full-length protein binding to target oligonucleotide,
KH1, by virtue of its highest binding afﬁnity, may form
the initial interaction. We speculate that this would enable
binding by KH2 through its restricted proximity to an
adjacent C-rich site on the RNA. KH3, also able to
bind independently to RNA, may bind at a nearby
C-rich site. Due to the capacity of aCP1 KH1 to form
homodimers or heterodimers with KH2, interactions
with other RNA bound aCPs may underlie the formation
of higher order multi-protein/RNA complexes that direct
the outcome for the RNA.
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